Abstract
Phototherapy has been used for centuries to treat various skin disorders. Numerous inflammatory skin diseases, such as atopic dermatitis and pigment disorders like vitiligo and psoriasis, benefit from ultraviolet light treatment. Psoralen-containing plants have been used for centuries in popular medicine to treat vitiligo, a skin disease characterized by lack of pigmentation. Further advancement in treatments using different psoralen molecules should strive to decrease the possibility of long-term side effects such as cutaneous malignancies. One of the directions for continued refinement of photochemotherapy in the future, as well as one of the new paradigms associated with photochemotherapy itself, is development of other psoralen molecules that do not form bifunctional adducts, which provide a basis for the DNA crosslinking. One such class of furanocoumarins is the methylangelicins (angular furanocoumarins) which only forms monofunctional adducts. There is clearly a theoretical basis that monofunctional adducts would less likely promote cutaneous malignancies as compared to bifunctional adducts. In this review we wish to present recent pharmacological approaches of furanocoumarins, particularly angular furanocoumarins, and a detailed investigation on the photocytotoxicity exerted by these compounds. Furthermore the edible vegetables and fruits which contain these compounds are showed.
Keywords: Psoriasis, vitiligo, phototherapy, natural and synthetic furanocoumarins
Current Drug Therapy
Title: Natural and Synthetic Furanocoumarins as Treatment for Vitiligo and Psoriasis
Volume: 4 Issue: 1
Author(s): Filomena Conforti, Mariangela Marrelli, Federica Menichini, Marco Bonesi, Giancarlo Statti, Eugenio Provenzano and Francesco Menichini
Affiliation:
Keywords: Psoriasis, vitiligo, phototherapy, natural and synthetic furanocoumarins
Abstract: Phototherapy has been used for centuries to treat various skin disorders. Numerous inflammatory skin diseases, such as atopic dermatitis and pigment disorders like vitiligo and psoriasis, benefit from ultraviolet light treatment. Psoralen-containing plants have been used for centuries in popular medicine to treat vitiligo, a skin disease characterized by lack of pigmentation. Further advancement in treatments using different psoralen molecules should strive to decrease the possibility of long-term side effects such as cutaneous malignancies. One of the directions for continued refinement of photochemotherapy in the future, as well as one of the new paradigms associated with photochemotherapy itself, is development of other psoralen molecules that do not form bifunctional adducts, which provide a basis for the DNA crosslinking. One such class of furanocoumarins is the methylangelicins (angular furanocoumarins) which only forms monofunctional adducts. There is clearly a theoretical basis that monofunctional adducts would less likely promote cutaneous malignancies as compared to bifunctional adducts. In this review we wish to present recent pharmacological approaches of furanocoumarins, particularly angular furanocoumarins, and a detailed investigation on the photocytotoxicity exerted by these compounds. Furthermore the edible vegetables and fruits which contain these compounds are showed.
Export Options
About this article
Cite this article as:
Conforti Filomena, Marrelli Mariangela, Menichini Federica, Bonesi Marco, Statti Giancarlo, Provenzano Eugenio and Menichini Francesco, Natural and Synthetic Furanocoumarins as Treatment for Vitiligo and Psoriasis, Current Drug Therapy 2009; 4 (1) . https://dx.doi.org/10.2174/157488509787081886
DOI https://dx.doi.org/10.2174/157488509787081886 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Immune System in Cancer
Current Pharmaceutical Biotechnology Is Fast Food Addictive?
Current Drug Abuse Reviews Functional Role of miR-34 Family in Human Cancer
Current Drug Targets Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery Phosphatidylinositol 3-kinase Glu545Lys and His1047Tyr Mutations are not Associated with T2D
Current Diabetes Reviews Potential Disease Targets for Drugs that Disrupt Protein - Protein Interactions of Grb2 and Crk Family Adaptors
Current Pharmaceutical Design Use of Biochemical and Microscopic Techniques to Determine Enhanced Skin Permeation of Nanovesicles: A Mechanistic Study
Pharmaceutical Nanotechnology Aptamers: Potential Applications to Pancreatic Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Gene Transfer and Drug Delivery with Electric Pulse Generators
Current Drug Metabolism Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease
Current Molecular Pharmacology Sodium Carbonate Sesquiperhydrate (2Na2CO3-3H2O2) Catalysed One-pot Synthesis of Biologically Dynamic Novel Substituted Spirooxirane Dicarboxamides
Current Catalysis Targeting the Cancer-Stroma Interaction: A Potential Approach for Pancreatic Cancer Treatment
Current Pharmaceutical Design “Non-Taxifolin” Derived Flavonolignans: Phytochemistry and Biology
Current Pharmaceutical Design Lymphatic Endothelial Cells, Inflammatory Lymphangiogenesis, and Prospective Players
Current Medicinal Chemistry Botanical Therapeutics (Part II): Antimicrobial and In Vitro Anticancer Activity against MCF7 Human Breast Cancer Cells of Chamomile, Parsley and Celery Alcoholic Extracts
Anti-Cancer Agents in Medicinal Chemistry Modulating Mesenchymal Stromal Cell Function with Cholesterol Synthesis Inhibitors
Current Medicinal Chemistry Common Aspects of Boronic Acids and Chalcogen Chemistry
Current Organic Chemistry Vitamins and Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets ROS-scavenging and Anti-tyrosinase Properties of Crocetin on B16F10 Murine Melanoma Cells
Anti-Cancer Agents in Medicinal Chemistry CPP-mediated Protein Delivery in a Noncovalent Form: Proof-of-Concept for Percutaneous and Intranasal Delivery
Protein & Peptide Letters